$LIFE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in aTYR PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in aTYR PHARMA INC. Get notifications about new insider transactions in aTYR PHARMA INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 11 2016 | LIFE | aTYR PHARMA INC | Matsuoka Grove | See Remarks | Buy | P | 3.03 | 10,000 | 30,300 | 12,412 | 2.4 K to 12.4 K (+414.59 %) |
May 11 2016 | LIFE | aTYR PHARMA INC | Matsuoka Grove | See Remarks | Buy | P | 3.08 | 2,412 | 7,429 | 2,412 | 0 to 2.4 K |
May 03 2016 | LIFE | aTYR PHARMA INC | Matsuoka Grove | See Remarks | Option Exercise | A | 3.67 | 145,000 | 532,150 | 145,000 | |
Apr 07 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 3.20 | 25,000 | 80,000 | 62,572 | 37.6 K to 62.6 K (+66.54 %) |
Apr 07 2016 | LIFE | aTYR PHARMA INC | MENDLEIN JOHN | CEO and Director | Buy | P | 3.52 | 2,500 | 8,800 | 250,971 | 248.5 K to 251 K (+1.01 %) |
Apr 06 2016 | LIFE | aTYR PHARMA INC | MENDLEIN JOHN | CEO and Director | Buy | P | 3.55 | 2,500 | 8,875 | 248,471 | 246 K to 248.5 K (+1.02 %) |
Apr 06 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 3.52 | 25,000 | 88,118 | 37,572 | 12.6 K to 37.6 K (+198.85 %) |
Apr 01 2016 | LIFE | aTYR PHARMA INC | Shukla Sanjay | Chief Medical Offic ... | Option Exercise | A | 4.86 | 163,000 | 792,180 | 163,000 | |
Mar 30 2016 | LIFE | aTYR PHARMA INC | Cubitt Andrew | VP, Product Protect ... | Option Exercise | A | 0.00 | 13,000 | 0 | 13,000 | |
Mar 30 2016 | LIFE | aTYR PHARMA INC | Blackburn Kelly | VP, Clinical Affair ... | Option Exercise | A | 0.00 | 21,600 | 0 | 21,600 | |
Apr 15 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 4.14 | 32,600 | 135,075 | 53,012 | 20.4 K to 53 K (+159.71 %) |
Apr 15 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 4.22 | 33,619 | 141,859 | 283,581 | 250 K to 283.6 K (+13.45 %) |
Apr 14 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 3.85 | 9,835 | 37,865 | 249,962 | 240.1 K to 250 K (+4.10 %) |
Apr 13 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 3.70 | 6,546 | 24,220 | 240,127 | 233.6 K to 240.1 K (+2.80 %) |
Apr 13 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 3.75 | 2,581 | 9,682 | 20,412 | 17.8 K to 20.4 K (+14.47 %) |
Apr 12 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 3.45 | 5,300 | 18,275 | 220,231 | 214.9 K to 220.2 K (+2.47 %) |
Apr 12 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 3.59 | 27,359 | 98,260 | 214,931 | 187.6 K to 214.9 K (+14.59 %) |
Apr 11 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 3.22 | 85,000 | 273,649 | 187,572 | 102.6 K to 187.6 K (+82.87 %) |
Apr 08 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 3.19 | 40,000 | 127,584 | 102,572 | 62.6 K to 102.6 K (+63.93 %) |
Jan 29 2016 | LIFE | aTYR PHARMA INC | AKKARAJU SRINIVAS | Director | Option Exercise | A | 6.14 | 19,428 | 119,288 | 19,428 | |
Jan 29 2016 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | A | 6.14 | 19,428 | 119,288 | 19,428 | |
Jan 29 2016 | LIFE | aTYR PHARMA INC | Blackburn Stan | Acting Chief Financ ... | Option Exercise | A | 6.14 | 4,250 | 26,095 | 4,250 | |
Jan 29 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | A | 6.14 | 19,428 | 119,288 | 19,428 | |
Jan 29 2016 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Gift | G | 0.00 | 11,925 | 0 | 634,242 | 646.2 K to 634.2 K (-1.85 %) |
Jan 29 2016 | LIFE | aTYR PHARMA INC | Krueger Nancy | VP, Legal Affairs | Option Exercise | A | 6.14 | 20,000 | 122,800 | 20,000 | |
Jan 29 2016 | LIFE | aTYR PHARMA INC | Goldberg Mark Alan | Director | Option Exercise | A | 6.14 | 19,428 | 119,288 | 19,428 | |
Jan 29 2016 | LIFE | aTYR PHARMA INC | Ashlock Melissa A. | See Remarks | Option Exercise | A | 6.14 | 18,250 | 112,055 | 18,250 | |
Jan 29 2016 | LIFE | aTYR PHARMA INC | FALBERG KATHRYN E | Director | Option Exercise | A | 6.14 | 19,428 | 119,288 | 19,428 | |
Jan 29 2016 | LIFE | aTYR PHARMA INC | Blackburn Kelly | VP, Clinical Affair ... | Option Exercise | A | 6.14 | 18,250 | 112,055 | 18,250 | |
Jan 29 2016 | LIFE | aTYR PHARMA INC | MENDLEIN JOHN | CEO and Director | Option Exercise | A | 6.14 | 135,000 | 828,900 | 135,000 | |
Jan 29 2016 | LIFE | aTYR PHARMA INC | McKew John C. | VP, Research | Option Exercise | A | 6.14 | 40,000 | 245,600 | 40,000 | |
Jan 29 2016 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Option Exercise | A | 6.14 | 19,428 | 119,288 | 19,428 | |
Jan 29 2016 | LIFE | aTYR PHARMA INC | Blake John T | Vice President, Fin ... | Option Exercise | A | 6.14 | 20,000 | 122,800 | 20,000 | |
Jan 29 2016 | LIFE | aTYR PHARMA INC | Chrzanowski Holly D. | See Remarks | Option Exercise | A | 6.14 | 8,500 | 52,190 | 8,500 | |
Jan 29 2016 | LIFE | aTYR PHARMA INC | Cubitt Andrew | VP, Product Protect ... | Option Exercise | A | 6.14 | 8,500 | 52,190 | 8,500 | |
Jan 29 2016 | LIFE | aTYR PHARMA INC | BLAIR JAMES C | Director | Option Exercise | A | 6.14 | 19,428 | 119,288 | 19,428 | |
Jan 06 2016 | LIFE | aTYR PHARMA INC | MENDLEIN JOHN | CEO and Director | Option Exercise | A | 9.13 | 148,732 | 1,357,923 | 148,732 | |
Jan 06 2016 | LIFE | aTYR PHARMA INC | McKew John C. | VP, Research | Option Exercise | A | 9.13 | 25,913 | 236,586 | 25,913 | |
Jan 06 2016 | LIFE | aTYR PHARMA INC | Krueger Nancy | VP, Legal Affairs | Option Exercise | A | 9.13 | 10,831 | 98,887 | 10,831 | |
Jan 06 2016 | LIFE | aTYR PHARMA INC | Graham Marcy | See Remarks | Option Exercise | A | 9.13 | 12,023 | 109,770 | 12,023 | |
Jan 06 2016 | LIFE | aTYR PHARMA INC | Cubitt Andrew | VP, Product Protect ... | Option Exercise | A | 9.13 | 16,874 | 154,060 | 16,874 | |
Jan 06 2016 | LIFE | aTYR PHARMA INC | Chrzanowski Holly D. | See Remarks | Option Exercise | A | 9.13 | 14,829 | 135,389 | 14,829 | |
Jan 06 2016 | LIFE | aTYR PHARMA INC | Blake John T | Vice President, Fin ... | Option Exercise | A | 9.13 | 5,038 | 45,997 | 5,038 | |
Jan 06 2016 | LIFE | aTYR PHARMA INC | Blackburn Stan | See Remarks | Option Exercise | A | 9.13 | 5,754 | 52,534 | 5,754 | |
Jan 06 2016 | LIFE | aTYR PHARMA INC | Blackburn Kelly | VP, Clinical Affair ... | Option Exercise | A | 9.13 | 26,470 | 241,671 | 26,470 | |
Jan 06 2016 | LIFE | aTYR PHARMA INC | Ashlock Melissa A. | See Remarks | Option Exercise | A | 9.13 | 29,659 | 270,787 | 29,659 | |
Jan 06 2016 | LIFE | aTYR PHARMA INC | Ravindran Sanuj K. | Chief Business Offi ... | Option Exercise | A | 9.13 | 10,750 | 98,148 | 10,750 | |
Jan 06 2016 | LIFE | aTYR PHARMA INC | Ravindran Sanuj K. | Chief Business Offi ... | Option Exercise | A | 9.13 | 153,000 | 1,396,890 | 153,000 | |
Oct 30 2015 | LIFE | aTYR PHARMA INC | Blake John T | Vice President, Fin ... | Option Exercise | A | 12.49 | 7,500 | 93,675 | 7,500 | |
Oct 05 2015 | LIFE | aTYR PHARMA INC | Ramsdell Fred | VP, Immunology | Option Exercise | A | 10.24 | 5,393 | 55,224 | 5,393 | |
Oct 05 2015 | LIFE | aTYR PHARMA INC | Ramsdell Fred | VP, Immunology | Option Exercise | A | 10.24 | 12,000 | 122,880 | 12,000 | |
Oct 05 2015 | LIFE | aTYR PHARMA INC | MENDLEIN JOHN | See Remarks | Option Exercise | A | 10.24 | 65,070 | 666,317 | 65,070 | |
Oct 05 2015 | LIFE | aTYR PHARMA INC | MENDLEIN JOHN | See Remarks | Option Exercise | A | 10.24 | 71,000 | 727,040 | 71,000 | |
Oct 05 2015 | LIFE | aTYR PHARMA INC | McKew John C. | VP, Research | Option Exercise | A | 10.24 | 11,337 | 116,091 | 11,337 | |
Oct 05 2015 | LIFE | aTYR PHARMA INC | McKew John C. | VP, Research | Option Exercise | A | 10.24 | 23,000 | 235,520 | 23,000 | |
Oct 05 2015 | LIFE | aTYR PHARMA INC | Krueger Nancy | VP, Legal Affairs | Option Exercise | A | 10.24 | 4,739 | 48,527 | 4,739 | |
Oct 05 2015 | LIFE | aTYR PHARMA INC | Krueger Nancy | VP, Legal Affairs | Option Exercise | A | 10.24 | 17,000 | 174,080 | 17,000 | |
Oct 05 2015 | LIFE | aTYR PHARMA INC | Graham Marcy | See Remarks | Option Exercise | A | 10.24 | 5,260 | 53,862 | 5,260 | |
Oct 05 2015 | LIFE | aTYR PHARMA INC | Graham Marcy | See Remarks | Option Exercise | A | 10.24 | 28,000 | 286,720 | 28,000 | |
Oct 05 2015 | LIFE | aTYR PHARMA INC | Cubitt Andrew | VP, Product Protect ... | Option Exercise | A | 10.24 | 7,382 | 75,592 | 7,382 | |
Oct 05 2015 | LIFE | aTYR PHARMA INC | Cubitt Andrew | VP, Product Protect ... | Option Exercise | A | 10.24 | 23,000 | 235,520 | 23,000 | |
Oct 05 2015 | LIFE | aTYR PHARMA INC | Chrzanowski Holly D. | See Remarks | Option Exercise | A | 10.24 | 6,488 | 66,437 | 6,488 | |
Oct 05 2015 | LIFE | aTYR PHARMA INC | Chrzanowski Holly D. | See Remarks | Option Exercise | A | 10.24 | 24,000 | 245,760 | 24,000 | |
Oct 05 2015 | LIFE | aTYR PHARMA INC | Blackburn Stan | See Remarks | Option Exercise | A | 10.24 | 2,518 | 25,784 | 2,518 | |
Oct 05 2015 | LIFE | aTYR PHARMA INC | Blackburn Stan | See Remarks | Option Exercise | A | 10.24 | 9,500 | 97,280 | 9,500 | |
Oct 05 2015 | LIFE | aTYR PHARMA INC | Blackburn Kelly | VP, Clinical Affair ... | Option Exercise | A | 10.24 | 11,581 | 118,589 | 11,581 | |
Oct 05 2015 | LIFE | aTYR PHARMA INC | Blackburn Kelly | VP, Clinical Affair ... | Option Exercise | A | 10.24 | 45,500 | 465,920 | 45,500 | |
Oct 05 2015 | LIFE | aTYR PHARMA INC | Ashlock Melissa A. | See Remarks | Option Exercise | A | 10.24 | 12,976 | 132,874 | 12,976 | |
Oct 05 2015 | LIFE | aTYR PHARMA INC | Ashlock Melissa A. | See Remarks | Option Exercise | A | 10.24 | 30,000 | 307,200 | 30,000 | |
Jul 10 2015 | LIFE | aTYR PHARMA INC | FALBERG KATHRYN E | Director | Option Exercise | A | 14.96 | 6,286 | 94,039 | 6,286 | |
Jul 10 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | A | 14.96 | 6,286 | 94,039 | 6,286 | |
Jul 10 2015 | LIFE | aTYR PHARMA INC | Goldberg Mark Alan | Director | Option Exercise | A | 14.96 | 6,286 | 94,039 | 6,286 | |
Jul 10 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | A | 14.96 | 6,286 | 94,039 | 6,286 | |
Jul 10 2015 | LIFE | aTYR PHARMA INC | AKKARAJU SRINIVAS | Director | Option Exercise | A | 14.96 | 6,286 | 94,039 | 6,286 | |
Jul 10 2015 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Option Exercise | A | 14.96 | 6,286 | 94,039 | 6,286 | |
Jul 10 2015 | LIFE | aTYR PHARMA INC | BLAIR JAMES C | Director | Option Exercise | A | 14.96 | 6,286 | 94,039 | 6,286 | |
May 14 2015 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Option Exercise | C | 0.00 | 1,536,787 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Option Exercise | C | 0.00 | 2,127,660 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Option Exercise | C | 0.00 | 4,320,173 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Option Exercise | C | 0.00 | 3,600,000 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Option Exercise | C | 0.00 | 2,400,000 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Option Exercise | C | 0.00 | 893,655 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Buy | C | 0.00 | 1,758,158 | 0 | 1,758,158 | 0 to 1.8 M |
May 14 2015 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Buy | C | 0.00 | 92,306 | 0 | 104,878 | 12.6 K to 104.9 K (+734.22 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | MENDLEIN JOHN | CEO and Executive C ... | Option Exercise | C | 0.00 | 21,122 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | MENDLEIN JOHN | CEO and Executive C ... | Option Exercise | C | 0.00 | 170,218 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | MENDLEIN JOHN | CEO and Executive C ... | Buy | C | 0.00 | 24,055 | 0 | 245,971 | 221.9 K to 246 K (+10.84 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 8,623 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 5,906 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 16,806 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 862,318 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 14,706 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 10,074 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 28,661 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 1,470,577 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 42,087 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 28,831 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 82,029 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 4,208,756 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 41,686 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 28,556 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 81,248 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 4,168,683 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 34,737 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 23,796 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 67,704 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 3,473,763 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 890 | 0 | 17,638 | 16.7 K to 17.6 K (+5.31 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 610 | 0 | 12,082 | 11.5 K to 12.1 K (+5.32 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 1,736 | 0 | 34,378 | 32.6 K to 34.4 K (+5.32 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 89,069 | 0 | 1,763,894 | 1.7 M to 1.8 M (+5.32 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 16,748 | 0 | 16,748 | 0 to 16.7 K |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 11,472 | 0 | 11,472 | 0 to 11.5 K |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 32,642 | 0 | 32,642 | 0 to 32.6 K |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 1,674,825 | 0 | 1,674,825 | 0 to 1.7 M |
May 14 2015 | LIFE | aTYR PHARMA INC | CHP II LP | 10% Owner | Option Exercise | C | 0.00 | 1,536,787 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | CHP II LP | 10% Owner | Option Exercise | C | 0.00 | 2,127,660 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | CHP II LP | 10% Owner | Option Exercise | C | 0.00 | 4,320,173 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | CHP II LP | 10% Owner | Option Exercise | C | 0.00 | 3,600,000 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | CHP II LP | 10% Owner | Option Exercise | C | 0.00 | 2,400,000 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | CHP II LP | 10% Owner | Buy | C | 0.00 | 1,758,158 | 0 | 1,758,158 | 0 to 1.8 M |
May 14 2015 | LIFE | aTYR PHARMA INC | AKKARAJU SRINIVAS | Director | Option Exercise | C | 0.00 | 14,968,722 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | AKKARAJU SRINIVAS | Director | Buy | P | 14.00 | 320,000 | 4,480,000 | 1,866,126 | 1.5 M to 1.9 M (+20.70 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | AKKARAJU SRINIVAS | Director | Buy | C | 0.00 | 1,546,126 | 0 | 1,546,126 | 0 to 1.5 M |
May 14 2015 | LIFE | aTYR PHARMA INC | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 893,655 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,126,866 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 4,361,703 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 4,320,173 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,600,000 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Alta Partners VIII, L.P. | 10% Owner | Buy | C | 0.00 | 92,306 | 0 | 1,778,064 | 1.7 M to 1.8 M (+5.48 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | Alta Partners VIII, L.P. | 10% Owner | Buy | C | 0.00 | 1,685,758 | 0 | 1,685,758 | 0 to 1.7 M |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 446,827 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 15,031 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 558,508 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 1,440,058 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 1,200,000 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 525,000 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 248,024 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | C | 0.00 | 46,152 | 0 | 646,167 | 600 K to 646.2 K (+7.69 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | C | 0.00 | 470,020 | 0 | 600,015 | 130 K to 600 K (+361.57 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | C | 0.00 | 31,181 | 0 | 31,181 | 0 to 31.2 K |
May 14 2015 | LIFE | aTYR PHARMA INC | Sofinnova Venture Partners IX, ... | 10% Owner | Option Exercise | C | 0.00 | 14,968,722 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Sofinnova Venture Partners IX, ... | 10% Owner | Buy | P | 14.00 | 320,000 | 4,480,000 | 1,866,126 | 1.5 M to 1.9 M (+20.70 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | Sofinnova Venture Partners IX, ... | 10% Owner | Buy | C | 0.00 | 1,546,126 | 0 | 1,546,126 | 0 to 1.5 M |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 8,623 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 5,906 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 16,806 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 862,318 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 14,706 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 10,074 | 0 | 0 |